Workflow
STERIS(STE)
icon
Search documents
STERIS(STE) - 2021 Q1 - Earnings Call Transcript
2020-12-08 17:44
Cantel Medical Corp. (CMD) Q1 2021 Earnings Conference Call December 8, 2020 8:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - CEO Chuck Diker - Chairman Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Brian Capone - SVP, Corporate Controller and Chief Accounting Officer Conference Call Participants Matt Mishan - KeyBanc Capital Markets Larry Keusch - Raymond James Mike Matson - Needham ...
STERIS(STE) - 2021 Q2 - Quarterly Report
2020-11-06 13:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-145506 ...
STERIS(STE) - 2020 Q4 - Earnings Call Transcript
2020-09-17 17:25
Cantel Medical Corp. (CMD) Q4 2020 Earnings Conference Call September 17, 2020 8:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - President and CEO Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Conference Call Participants Larry Keusch - Raymond James Matthew Mishan - KeyBanc Capital Markets Mitra Ramgopal - Sidoti & Company Mike Matson - Needham & Company Operator Hello, everyone, and ...
STERIS(STE) - 2020 Q4 - Earnings Call Presentation
2020-09-17 12:34
4th Quarter FY20 Earnings Call September 17th, 2020 2 Forward Looking Statements This press release contains "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forwardlooking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, estima ...
STERIS(STE) - 2021 Q1 - Quarterly Report
2020-08-07 12:39
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 (St ...
STERIS(STE) - 2020 Q3 - Earnings Call Transcript
2020-06-04 16:38
Cantel Medical Corp. (CMD) Q3 2020 Results Earnings Conference Call June 4, 2020 8:30 AM ET Company Participants Matthew Micowski - VP, IR and Financial Planning and Analysis George Fotiades - President and Chief Executive Officer Shaun Blakeman - Senior Vice President and Chief Financial Officer Seth Yellin - Executive Vice President, Strategy and Corporate Development Peter Clifford - Executive Vice President and Chief Operating Officer Conference Call Participants Lawrence Keusch - Raymond James Financia ...
STERIS(STE) - 2020 Q3 - Earnings Call Presentation
2020-06-04 14:42
NYSE:CM N 3rd Quarter FY20 Earnings Call June 4th, 2020 Forward Looking Statements 2 This press release contains "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forwardlooking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, es ...
STERIS(STE) - 2020 Q4 - Annual Report
2020-05-29 12:54
For the fiscal year ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 United States Securities and Exchange Commission Washington, D. C. 20549 __________________________________________________________________ FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ Commission file number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...
STERIS(STE) - 2020 Q2 - Earnings Call Transcript
2020-03-05 16:25
Cantel Medical Corp. (CMD) Q2 2020 Earnings Conference Call March 5, 2020 8:30 AM ET Company Participants Matt Micowski - Investor Relations Chuck Diker - Chairman of the Board George Fotiades - President & Chief Executive Officer Peter Clifford - Executive Vice President & Chief Operating Officer Seth Yellin - Executive Vice President & Chief Growth Officer Shaun Blakeman - Senior Vice President & Chief Financial Officer Brian Capone - Senior Vice President, Corporate Controller & Chief Accounting Officer. ...
STERIS(STE) - 2020 Q2 - Earnings Call Presentation
2020-03-05 13:46
NYSE:CM N 2nd Quarter FY20 Earnings Call March 5th, 2020 Forward Looking Statements 2 This presentation may contain "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations ...